ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASTH vs MAN // FORWARD P/E MULTIPLE

Astrana Health Inc. (NASDAQ) VS. ManpowerGroup (NYSE) • 15-METRIC TALLY: ASTH 5 — MAN 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASTH VS. MAN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASTH MAN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 16.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 4.60% 5.30% -0.70 MAN /roic <GO>
EV/EBITDA & P/E Valuation 27.3x 15.3x +12.00 MAN /valuation <GO>
Free Cash Flow Yield 5.75% -4.92% +10.67 ASTH /fcf-yield <GO>
Operating Margin 2.50% 0.80% +1.70 ASTH /operating-margins <GO>
Net Profit Margin 0.80% — — TIE /net-margins <GO>
Revenue Growth (YoY) 56.40% 0.60% +55.80 ASTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.43% 3.15% -2.72 MAN /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.54 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 2/9 +4.00 ASTH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 40.4 +6.37 ASTH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 63.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.82B $2.12B -$299.0M MAN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASTH REV MAN REV ASTH GROSS % MAN GROSS % ASTH FCF MAN FCF
FY 2025 $3.18B $17.96B — 16.7% $104.5M -$104.1M
FY 2024 $2.03B $17.85B — 17.3% $44.2M $309.2M
FY 2023 $1.39B $18.91B — — $68.2M $348.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASTH // BETA —
MAN // BETA —